Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Evogene Ltd. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +1 vs. Q3 2024
- Shares held
- 401.9K
- −150.6K (−27.3%) vs. Q3 2024
- Total value
- $751.6K
- −$944.4K (−55.7%) vs. Q3 2024
- New holders
- 5
- 5 more added
- Sold out
- 4
- 1 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $120.0K |
| Q1 2026 | 15 | $408.9K |
| Q4 2025 | 18 | $199.8K |
| Q3 2025 | 14 | $176.1K |
| Q2 2025 | 16 | $166.9K |
| Q1 2025 | 16 | $526.9K |
| Q4 2024 | 15 | $751.6K |
| Q3 2024 | 14 | $1.70M |
| Q2 2024 | 28 | $2.55M |
| Q1 2024 | 29 | $3.04M |
| Q4 2023 | 33 | $3.69M |
| Q3 2023 | 35 | $2.73M |
| Q2 2023 | 28 | $759.5K |
| Q1 2023 | 27 | $500.6K |
| Q4 2022 | 31 | $753.9K |
| Q3 2022 | 26 | $1.21M |
| Q2 2022 | 29 | $1.25M |
| Q1 2022 | 38 | $3.18M |
| Q4 2021 | 43 | $10.0M |
| Q3 2021 | 39 | $16.7M |
| Q2 2021 | 44 | $25.3M |
| Q1 2021 | 46 | $42.1M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Evogene Ltd.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 298,281 | $557.8K | 0.01% | +103,589+53.2% | Added |
| UBS Group AG | 22,012 | $41.2K | 0.00% | +13,411+155.9% | Added |
| Jane Street Group, LLC | 21,345 | $39.9K | 0.00% | +21,345 | New |
| Citadel Advisors LLC | 15,891 | $29.7K | 0.00% | +15,891 | New |
| Morgan Stanley | 14,586 | $27.3K | 0.00% | +1,981+15.7% | Added |
| BNP Paribas Arbitrage, SA | 12,819 | $24.0K | 0.00% | +619+5.1% | Added |
| Two Sigma Securities, LLC | 11,159 | $20.9K | 0.00% | +11,159 | New |
| JPMorgan Chase & Co | 4,161 | $7.78K | 0.00% | +3,522+551.2% | Added |
| Advisor Group Holdings, Inc. | 540 | $1.08K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 500 | $935 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 500 | $935 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 72 | $135 | 0.00% | +72 | New |
| Synergy Financial Management, LLC | 20 | $61 | 0.00% | +20 | New |
| Bank of America Corp | 6 | $11 | 0.00% | −132−95.7% | Reduced |
| Royal Bank of Canada | 42 | $0 | 0.00% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −307,974−100.0% | Sold out |
| Renaissance Investment Group LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −3,803−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −290−100.0% | Sold out |